A First-In-Human Study of RO5503781 in Participants With Advanced Malignancies Except Leukemia

NCT01462175 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
99
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Hoffmann-La Roche